Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
86.1M
-
Number of holders
-
153
-
Total 13F shares, excl. options
-
52.6M
-
Shares change
-
+6.15M
-
Total reported value, excl. options
-
$526M
-
Value change
-
+$60.4M
-
Put/Call ratio
-
0.97
-
Number of buys
-
81
-
Number of sells
-
-62
-
Price
-
$10.00
Significant Holders of Liquidia Corp - Common Stock, par value $0.001 per share (the "Shares") (LQDA) as of Q3 2024
188 filings reported holding LQDA - Liquidia Corp - Common Stock, par value $0.001 per share (the "Shares") as of Q3 2024.
Liquidia Corp - Common Stock, par value $0.001 per share (the "Shares") (LQDA) has 153 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.6M shares
of 86.1M outstanding shares and own 61.06% of the company stock.
Largest 10 shareholders include Caligan Partners LP (8.12M shares), Patient Square Capital LP (7.18M shares), BlackRock, Inc. (4.21M shares), VANGUARD GROUP INC (3.44M shares), FARALLON CAPITAL MANAGEMENT LLC (3.29M shares), FINDELL CAPITAL MANAGEMENT LLC (3.19M shares), Kynam Capital Management, LP (2.27M shares), STATE STREET CORP (2.18M shares), Whitefort Capital Management, LP (1.7M shares), and Opaleye Management Inc. (1.7M shares).
This table shows the top 153 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.